The fundamental disadvantage of these models is that these animals do not develop AD in the absence of artificially elicited AD-like brain lesions or genetic manipulation (e.g., overexpression of APP or PSEN1 in transgenic mice). The gene discussed is PSEN1; the disease is Alzheimer disease.